less toxic

A new study of more than 9,000 people suggests that elderly mesothelioma patients would likely live longer if treatments could be found that are “less toxic” than current chemotherapy. A European team of cancer researchers analyzed mesothelioma treatment trends by location and by age group and found that younger patients are more likely to have – and to benefit from – chemotherapy for mesothelioma. Although older mesothelioma patients often have chemotherapy, too, they are more likely to die from treatment-related complications. The study focused on three countries with high mesothelioma rates – Belgium, the Netherlands, and England. It included a total of 900 mesothelioma patients from the Belgian Cancer Registry, 2309 from the Netherlands Cancer Registry, and 5808 from the…